South African researchers have provided a glimmer of hope for the
millions of people in the developing world struck down by
tuberculosis (TB) by developing a nano-sized drug delivery platform
that could make all the difference in...
According to the international medical humanitarian organisation
Médecins Sans Frontières (MSF), the World Health Organisation (WHO)
has failed to address the emergence of extensively drug-resistant
A new study has revealed the existence of new drug targets for
tuberculosis (TB) treatments, which could essentially dictate the
design of TB drugs of the future. The bacterium that causes TB
currently infects one person in three...
Oxford Immunotec makes available an in vitro diagnostic that
measures T-cells specific to Mycobacterium tuberculosis (MTB)
antigens diagnosing both latent and active TB infection in
immunocompromised humans - a significant problem...
A new laboratory application for detecting tuberculosis, which cuts
waiting time from 24 hours to three minutes using a technique that
identifies TB antigens, has been made available by Proteome
Systems. The application is set to...
Researchers have uncovered a novel treatment that could prove to be
effective against tuberculosis (TB), a disease that has made a
comeback due to the emergence of resistant strains of the offending
bacterium and the spread of AIDS.
A class of drug, which is currently used to fight respiratory tract
infections, has demonstrated pharmacological features and potential
antibacterial drug activity that may prove effective against
Tuberculosis, which is currently...
A novel approach to treating tuberculosis (TB), focusing on a
potential drug target in the cell walls of Mycobacterium
tuberculosis, the bacterium that causes TB, a disease that is
reappearing as new, multiresistant drug-strains.
The European Commission has announced a collaborative tuberculosis
research initiative, underpinned by €32 million in funding for two
overlapping research projects aimed at developing an improved
vaccine for the disease. The news...